ROSSARI2024-04-012024-06-30 ROSSARI2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member ROSSARI2024-06-30 ROSSARI2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543213 ROSSARI NOTLISTED Rossari Biotech Limited Equity 2024-04-01 2025-03-31 2024-07-20 2024-07-12 INR Millions First quarter 17:45:00 19:05:00 2024-07-20 2024-07-20 Not applicable Single segment Manufacturing of Specialty Chemicals for Textile, Home and Personal Care, Performance Chemicals and Animal Health and Nutrition industries 2024-04-01 2024-06-30 Unaudited Consolidated 4896500000.00 9480000.00 4905980000.00 2840340000.00 425530000.00 143140000.00 285840000.00 36850000.00 153720000.00 552790000.00 4438210000.00 467770000.00 0.00 467770000.00 152570000.00 -31690000.00 120880000.00 0.00 346890000.00 0.00 0.00 0.00 2100000.00 348990000.00 20000.00 349010000.00 349020000.00 0.00 110490000.00 2 6.32 6.30 0.00 0.00 6.32 6.30 Notes:1.The financial results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meeting held on 20.07.2024.2.The consolidated financial results have been prepared in accordance with the recognition and measurement principles laid down under Indian Accounting Standard (Ind AS) 34 on Interim Financial Reporting as prescribed under Sec 133 of the Companies Act,2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.3.The Group deals in Specialty chemicals and considering that the nature of products and the predominant risk and returns of the products are similar, the Company considers it as one operating segment.4.During the quarter ended 30.06.2024, the Parent Company has incorporated a wholly owned subsidiary 'Rossari Global DMCC' in UAE w.e.f. 31.05.2024.5.During the quarter ended 30.06.2024, the Parent Company has allotted 1,500 equity shares of Rs.2.00 each pursuant to exercise of options under the approved Rossari Employee Stock Option Plan-2019.6.The figures for the quarter ended 31.03.2024 are the balancing figures between the audited figures in respect of the full financial year and the unaudited published figures upto nine months of the relevant financial year.7.Previous year/period figures have been regrouped to make them comparable with the current year/period figures, which are not material. For ROSSARI BIOTECH LIMITED EDWARD MENEZES Executive Chairman DIN:00149205 Place : Mumbai Date:20.07.2024 Other Expenses 552790000.00 Remeasurements of the defined benefit plans 30000.00 30000.00 10000.00 0.00